Dexin Corporation (TPEX:3349)

Dexin Statistics

Total Valuation

Dexin has a market cap or net worth of TWD 1.28 billion. The enterprise value is 1.13 billion.

Market Cap	1.28B
Enterprise Value	1.13B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Dexin has 46.07 million shares outstanding. The number of shares has increased by 6.89% in one year.

Current Share Class	46.07M
Shares Outstanding	46.07M
Shares Change (YoY)	+6.89%
Shares Change (QoQ)	+2.39%
Owned by Insiders (%)	10.30%
Owned by Institutions (%)	n/a
Float	25.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.67
PB Ratio	3.71
P/TBV Ratio	3.84
P/FCF Ratio	17.84
P/OCF Ratio	17.11
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.68
EV / Sales	2.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.70

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.16.

Current Ratio	2.99
Quick Ratio	2.37
Debt / Equity	0.16
Debt / EBITDA	16.73
Debt / FCF	0.76
Interest Coverage	-8.10

Financial Efficiency

Return on equity (ROE) is -13.53% and return on invested capital (ROIC) is -12.85%.

Return on Equity (ROE)	-13.53%
Return on Assets (ROA)	-2.99%
Return on Invested Capital (ROIC)	-12.85%
Return on Capital Employed (ROCE)	-6.46%
Weighted Average Cost of Capital (WACC)	5.48%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.89
Inventory Turnover	5.93

Taxes

In the past 12 months, Dexin has paid 9.17 million in taxes.

Income Tax	9.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.33% in the last 52 weeks. The beta is 0.23, so Dexin's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+52.33%
50-Day Moving Average	28.29
200-Day Moving Average	23.29
Relative Strength Index (RSI)	51.76
Average Volume (20 Days)	198,133

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dexin had revenue of TWD 479.32 million and -43.89 million in losses. Loss per share was -1.02.

Revenue	479.32M
Gross Profit	96.25M
Operating Income	-25.87M
Pretax Income	-34.72M
Net Income	-43.89M
EBITDA	-9.06M
EBIT	-25.87M
Loss Per Share	-1.02

Balance Sheet

The company has 208.40 million in cash and 54.62 million in debt, with a net cash position of 153.78 million or 3.34 per share.

Cash & Cash Equivalents	208.40M
Total Debt	54.62M
Net Cash	153.78M
Net Cash Per Share	3.34
Equity (Book Value)	345.57M
Book Value Per Share	7.50
Working Capital	234.99M

Cash Flow

In the last 12 months, operating cash flow was 74.85 million and capital expenditures -3.04 million, giving a free cash flow of 71.81 million.

Operating Cash Flow	74.85M
Capital Expenditures	-3.04M
Depreciation & Amortization	16.81M
Net Borrowing	-10.92M
Free Cash Flow	71.81M
FCF Per Share	1.56

Margins

Gross margin is 20.08%, with operating and profit margins of -5.40% and -9.16%.

Gross Margin	20.08%
Operating Margin	-5.40%
Pretax Margin	-7.24%
Profit Margin	-9.16%
EBITDA Margin	-1.89%
EBIT Margin	-5.40%
FCF Margin	14.98%

Dividends & Yields

Dexin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.89%
Shareholder Yield	-6.89%
Earnings Yield	-3.43%
FCF Yield	5.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 30, 2022. It was a forward split with a ratio of 1.04.

Last Split Date	Aug 30, 2022
Split Type	Forward
Split Ratio	1.04

Scores

Dexin has an Altman Z-Score of 3.56 and a Piotroski F-Score of 5.

Altman Z-Score	3.56
Piotroski F-Score	5